BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11139723)

  • 1. [Magnetic resonance spectroscopy in multiple sclerosis].
    Viala K; Stievenart JL; Cabanis EA; Lyon-Caen O; Tourbah A
    Rev Neurol (Paris); 2000 Dec; 156(12):1078-86. PubMed ID: 11139723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
    Narayana PA; Doyle TJ; Lai D; Wolinsky JS
    Ann Neurol; 1998 Jan; 43(1):56-71. PubMed ID: 9450769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
    Tartaglia MC; Narayanan S; De Stefano N; Arnaoutelis R; Antel SB; Francis SJ; Santos AC; Lapierre Y; Arnold DL
    J Neurol; 2002 Oct; 249(10):1382-90. PubMed ID: 12382153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study with localized proton magnetic resonance spectroscopy of 31 multiple sclerosis lesions: correlations with clinical and MRI features].
    Viala K; Stievenart JL; Cabanis EA; Lyon-Caen O; Tourbah A
    Rev Neurol (Paris); 2001 Jan; 157(1):35-44. PubMed ID: 11240546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
    Watanabe H; Fukatsu H; Ito T; Iijima M; Mabuchi N; Sobue G
    Nihon Rinsho; 2003 Aug; 61(8):1435-41. PubMed ID: 12962035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
    Mathiesen HK; Langkilde AR; Larsson HB
    Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black holes in multiple sclerosis: definition, evolution, and clinical correlations.
    Sahraian MA; Radue EW; Haller S; Kappos L
    Acta Neurol Scand; 2010 Jul; 122(1):1-8. PubMed ID: 20003089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.
    Srinivasan R; Sailasuta N; Hurd R; Nelson S; Pelletier D
    Brain; 2005 May; 128(Pt 5):1016-25. PubMed ID: 15758036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
    Ranjeva JP; Audoin B; Pelletier J; Confavreux C
    Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J; Pelletier D; Nelson SJ
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picturing multiple sclerosis: conventional and diffusion tensor imaging.
    Fox RJ
    Semin Neurol; 2008 Sep; 28(4):453-66. PubMed ID: 18843574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M; Grossman RI; Filippi M
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
    Placidi G; Sabatini M; Gallucci M; Sotgiu A
    Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.